Author: Daniel snow

[ad_1] Janine Kraft, store manager of the Tante Enso store in Wörlitz, Germany, sorts goods onto the shelves.Picture Alliance | Picture Alliance | Getty ImagesGermany’s annual inflation rate unexpectedly eased to 2% in June, bringing Europe’s largest economy in line with the European Central Bank’s target, preliminary data from statistics office Destatis showed Monday.Analysts polled by Reuters had expected a reading of 2.2% in the twelve months to June.The German print is harmonized across the euro zone, allowing for a direct comparison with other single currency states. The consumer price index had eased to 2.1% in the year to May.Elsewhere…

Read More

[ad_1] Tom LeeAdam Jeffery | CNBC Fundstrat’s Tom Lee is joining a little known bitcoin miner aiming to become the biggest publicly traded holder of ether.Lee, a high-profile market strategist known for his prescient bitcoin price forecasts and stock predictions, has been appointed chairman of the board of directors of BitMine Immersion Technologies, effective Monday. The company also announced a $250 million private placement to implement a buying strategy around ether, which it aims to make its primary treasury reserve asset while continuing with its core bitcoin mining business.Lee’s appointment comes amid a groundswell of interest around stablecoins following the…

Read More

[ad_1] With a simple menu and company-owned restaurants, Raising Cane’s has quietly surpassed KFC in annual U.S. sales, becoming the third-largest chicken chain in the country.The accomplishment follows a recent winning streak for the 28-year-old company, which has spent the last decade expanding outside its home bases in Louisiana and Texas. Its restaurant footprint has grown to more than 900 locations, up from just over 500 in 2020. Last year, it opened 118 restaurants. About 100 are expected to open this year, with another 200 or so in the development pipeline.Cane’s told CNBC that its system sales rose to $5.1…

Read More

[ad_1] The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024.Adam Glanzman | Bloomberg | Getty ImagesModerna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and Covid jab.Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza, saying it had plans to resubmit it with efficacy data from the phase three trial on its standalone flu vaccine. That decision came after discussions with the Food…

Read More